Drug intelligence / Profile preview

Oxifit 2K-7

Development stage
Unknown
Lead developer
Boffin Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Oxifit 2K-7 (also referred to as Oxifit K2-7) is a fixed-dose combination softgel capsule developed and manufactured by Boffin Biotech. It is formulated as a nutritional supplement to support bone health, joint integrity, and peripheral nerve function, particularly in conditions such as osteoporosis, osteomalacia, and peripheral neuropathy. The combination contains five active ingredients: calcitriol (the active form of vitamin D3), calcium carbonate, vitamin K2-7 (menaquinone-7), methylcobalamin (the active coenzyme form of vitamin B12), and folic acid. Calcitriol and calcium carbonate work synergistically to promote calcium absorption and maintain bone mineral density. Vitamin K2-7 acts as a cofactor for the gamma-carboxylation of osteocalcin and matrix Gla protein, directing calcium to the bones and preventing vascular calcification. Methylcobalamin and folic acid support nerve regeneration, myelin sheath formation, and homocysteine metabolism, helping to alleviate neuropathic pain and improve neuronal function.

Brand names
Oxifit 2K-7Oxifit2K-7Oxifit-2K-7Oxifit K2-7
Other names
calcitriol + calcium carbonate + folic acid + methylcobalamin + vitamin K2-7
02

Targets

CaSR (Extracellular calcium-sensing receptor)DHFR (Dihydrofolate reductase)FOLR1 (FRα)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)MTR (Methionine synthase)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Oxifit 2K-7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxifit 2K-7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call